Introduction
Burkitt's lymphoma (Burkitt, 1958) cells are characterized by a balanced, reciprocal translocation fusing the proto-oncogene c-myc located on chromosome 8 (Dalla-Favera et al., 1982) to one of the immunoglobulin gene loci. In the most frequent translocation t(8;14) the breakpoint lies in the 5'-region of c-myc, whereas in the so called variant translocations c-myc remains on chromosome 8, while parts of either chromosome 2 (Ig k locus) or chromosome 22 (Ig l locus) become juxtaposed within a variable distance 3' of c-myc (Bornkamm et al., 1988; Magrath, 1990; Joos et al., 1992) . The deregulated c-myc expression caused by these translocations is thought to play a major role in the pathogenesis of Burkitt's lymphoma.
The translocated c-myc gene in BL cells displays several features: (i) it is highly expressed whereas the normal allele is transcriptionally silent or expressed at very low levels; (ii) the P1 promoter is the preferential site of transcriptional initiation, in contrast to the normal c-myc gene where 80 ± 90% of total c-myc RNA is derived from the P2 promoter; (iii) the c-myc gene is structurally altered at the ®rst exon/intron boundary; (iv) the block to RNA elongation is functionally missing; and (v) expression of the translocated allele is transcriptionally downregulated by sodium butyrate.
The c-myc deregulation in BL cells seems to be dependent upon the colocalization of c-myc and one of the immunoglobulin loci (Bornkamm et al., 1988; Cory, 1986; Magrath, 1990) . In the case of t(8;14) translocations, which link the c-myc gene to the immunoglobulin heavy chain locus, it has been shown that the m intron enhancer, the 3' Ca enhancer and the Ca¯anking matrix attachment region are required for c-myc deregulation (Hayday et al., 1984; Madisen et al., 1994) . For the immunoglobulin k locus it has also been demonstrated that three elements are necessary for the BL cell speci®c deregulation: only the interplay of the k intron enhancer (Ei), 3'-enhancer (E3') and the matrix attachment region (MAR) causes c-myc overexpression, promoter shift and the absence of the RNA elongation block (HoÈ rtnagel et al., 1995; Polack et al., 1993) .
In contrast, little is known about the regulatory elements within the Ig l locus responsible for c-myc deregulation in the variant t(8;22) translocation. Blomberg et al. (1991) identi®ed a strong B-cell speci®c enhancer element in the 3' region of the human l locus, which appeared to be a prime candidate for causing cmyc deregulation in BL cells. In addition, Asenbauer and Klobeck (1996) have reported several DNaseI hypersensitive sites (HSS) between the Cl7 gene and the l enhancer. This region is juxtaposed to c-myc on chromosome 8 in all of the t(8;22) translocations mapped to date, since the breakage takes place 5' of the Cl genes (Hartl and Lipp 1987; Hollis et al., 1984; Showe et al., 1987; Zeidler et al., 1994) . We have therefore chosen a 12 kb fragment encompassing exactly this region to investigate its eect on c-myc expression
In this paper we present the results of transient and stable transfection experiments that led to the identi®cation of additional regulatory elements within the Ig l locus which, in conjunction with the l enhancer, are required for full c-myc activation and induction of the promoter shift.
Results
A 12 kb genomic fragment encompassing the human l enhancer induces c-myc activation and promoter shift in BL cells whereas the l enhancer alone does not
To identify the element(s) responsible for c-myc deregulation after t(8;22) translocation, we cloned genomic fragments from the Ig l locus and studied their eect on c-myc expression after stable transfection in BL cells. Since most, if not all, Vl gene segments have the same orientation relative to the J-C gene segments and therefore rearrange by a deletion mechanism (Combriato et al., 1991) , we focused our studies on the region 3' of Cl7. The human l enhancer, which appeared to be a likely candidate for mediating c-myc activation, also maps to this region. As shown in Figure  1a , 12 kb BglII-BglII fragment encompassing the l enhancer, as well as a number of smaller enhancer carrying fragments, were subcloned from cosmid ST107 into plasmid pRF115-3 (Figure 1 ). This pHEBO vector (Sugden et al., 1985) based plasmid contains the HindIII-EcoRI c-myc gene, which has been functionally inactivated by a frameshift mutation in order to avoid negative autoregulation by the Myc protein (Polack et al., 1991) . Since pHEBO replicates as an episome, it allows for the study of gene regulation without interfering positional eects. All plasmids were transfected into the EBV positive BL cell line Raji, which carries a t(8;14) translocation (Pulvertaft, 1964) . Exon 1 of the translocated c-myc allele in Raji cells is heavily mutated. Using an exon 1 speci®c probe it is therefore possible to distinguish in S1 nuclease experiments between transcripts derived from the endogenous translocated c-myc allele and those derived from the transfected constructs. Raji cells also exhibit a prominent promoter shift, which indicates that all necessary trans-acting factors are expressed and, in addition, served as an internal control in S1 nuclease experiments (Rabbits et al., 1983) . For each construct several stable transfectants were obtained and analysed. The integrity of the plasmids as well as the number of copies (20 ± 30 per cell) was con®rmed by Southern blot analysis (data not shown).
Northern blot (Figure 2 ) analysis of the stable transfectants revealed that the 12 kb l fragment on construct pBC83 strongly induced c-myc expression, whereas the enhancer activity of all truncated versions was markedly reduced. Deletion of the 5' BglII-BamHI fragment (pBC164) resulted in a 60% decrease in c-myc transcripts. Further deletion of the region 5' to the l enhancer had no detectable eect on c-myc expression. S1 nuclease analysis (Figure 3 ) of the stable transfectants con®rmed these results with respect to total c-myc RNA. Compared to the reference clone pRF245-10, which contains all the Ig k elements responsible for c-myc deregulation after t(2;8) translocation , the activation of the P1 promoter by the 12 kb fragment (pBC83) was 2.5-fold higher. Likewise, the total amount of c-myc RNA was greatly reduced after deletion of the 5' BglII-BamHI fragment but further deletions had either no eect or a slight activating eect. In contrast to these quantitative similarities, qualitative dierences in c-myc expression between the various constructs became evident. The l enhancer alone (pBC68) strongly activated c-myc transcription, with most of the transcripts initiated at the P2 promoter. Adding the adjacent upstream sequences (pBC123) did not aect the total amount of c-myc transcripts made, but did cause a shift in promoter usage. Therefore, at least two additional regulatory elements aside from the l enhancer must be located on the 12 kb fragment: the area at the 5'region of pBC83 synergizes with the l enhancer in the activation of the P1 promoter. The sequence, located 5' of the enhancer (pBC 123), shifts the usage of the promoter towards P1.
Four DNaseI hypersensitive sites are formed on the stably transfected 12 kb l fragment Functionally active regulatory elements, such as promoters or enhancers, display altered chromosomal structures that are hypersensitive to cleavage by nucleases (Gross et al., 1988) . In order to map the putative regulatory elements on the 12 kb fragment more precisely, we examined the chromatin structure of the stably transfected construct pBC83 ( Figure 1b ). Using two dierent restriction enzymes and probes, four DNaseI hypersensitive sites were detected ( Figure  4 ). One of these sites (HSS III) is associated with the l enhancer described by Blomberg et al. (1991) , whereas HSSs I and II correspond to the HSSs recently described by Asenbauer and Klobeck (1996) . In addition, a new site was detected at the very 5' end of the fragment, which we have termed HSS 0. The high number of constructs expressed per cell may have facilitated detection of this weak HSS, which has not been described in the endogenous l locus.
HSS I, HSS II and HSS III display enhancer activity in transient transfection assays whereas HSS 0 does not
To test if the sequence elements residing within the DNaseI HSSs display enhancer activity, transient transfection experiments were performed using the luciferase gene as a reporter. Fragments encompassing these sites were cloned downstream of the luciferase gene driven by the KpnI-XhoI c-myc promoter fragment as shown in Figure 5a . The luciferase activity seen after transient transfection into BL Raji cells is shown in Figure 5b . Compared to the parental plasmid RF211-1, the l enhancer activated the P1 promoter approximately 200-fold. HSS I and HSS II also showed transcriptional enhancer acivity and induced the P1 promoter up to 25-fold (HSS I) and ®vefold (HSS II), respectively. Unexpectedly, HSS 0 showed no enhancer activity in transient transfection assays. This was surprising, because the importance of this fragment on c-myc expression after the stable transfection has been apparent.
Dierent elements within the c-myc promoter are required for c-myc activation and induction of the promoter shift
The eect of enhancers on transcription requires their interaction with the promoter. This interaction has c-myc deregulation in Burkitt's lymphoma A Gerbitz et al been poorly understood until now. In order to de®ne the c-myc promoter region necessary for activation by the Ig l locus, we generated three dierent c-myc promoter constructs using the restriction sites HindIII (72324 bp relative to P1, pBC83), KpnI (71056 bp/ P1, AG132) and SmaI (7101 bp/P1, AG133) ( Figure  1b ). We then examined c-myc expression after stable transfection in S1 nuclease experiments ( Figure 6 ). Deletion of the region 72324 bp to 71056 bp relative to P1 (AG132) had at most a marginal eect on c-myc expression. Further deletions, however, abolished the promoter shift, although the total amount of c-myc RNA remained unchanged (AG 133). In transient transfection assays we could demonstrate that a SmaIXhoI P1 promoter construct can be fully activated by the 12 kb l fragment compared to KpnI and HindIII promoter constructs (data not shown). Thus, elements in the immediate c-myc promoter region (7101 bp/P1) P-radiolabelled GAPDH probe was added to the hybridization mixture to standardize the total amount of RNA loaded per lane (Polack et al., 1991 . (b) Results of the scanning of relative activity using a Fuji Fujix BAS 1000 phosphoimager. The bars show the total amount of c-myc RNA in relative scan units (RSC) Figure 3 (a) S1 Nuclease protection analysis of Raji cells stably transfected with the constructs pRF115-3, pRF245-10, pBC83, pBC164, pBC123 and pBC68. Total cellular RNA of the transfectants and untransfected Raji cells were analysed using the probe shown in (c). P1 and P2 correspond to c-myc transcripts initiated at the P1 and P2 promoters of the plasmid. As shown in (c), the 3' part of c-myc exon 1 is deleted in Raji cells, therefore, endogenous c-myc transcripts from the translocated allele (P1t and P2t) can be distinguished from transcripts derived from the stably transfected plasmids (P1 and P2). Raji cells, or Raji cells stably transfected with the parental plasmid pRF115-3, which does not contain any L sequences, show expression of the endogenous translocated cmyc allele only. BL60, a Burkitt's lymphoma cell line with a t(8;22) translocation (no truncation within the ®rst exon) was included as control. As veri®ed by GAPDH hybridization, equal amounts of RNA were tested in each sample (data not shown). Activation of the P1 promoter through the Ig l elements can be downregulated by sodium butyrate
Treatment of BL cells with sodium butyrate speci®cally downregulates transcription of the translocated c-myc gene and slightly induces P2 transcription from the normal allele (Anisimova et al., 1982; Eick et al., 1986; Polack et al., 1987 Polack et al., , 1993 Rottleb et al., 1995 Rottleb et al., , 1996 . The precise mechanism of this eect is not known. As shown in Figure 6 , induction of the P1 promoter by the 12 kb l fragment can be reverted by sodium butyrate (pBC83 and pAG132). P2 transcription of constructs pBC83 and pAG132 was not aected. Sodium butyrate also did not have any eect on P1 transcription of construct AG133, which did not show a promoter shift. This further supports the notion that all elements contributing to c-myc deregulation in BL cells (including the sodium butyrate sensitive element) are present in the 12 kb l fragment.
Discussion
A common feature shared by many hematological malignancies is the deregulation of genes involved in cell growth, survival and dierentiation by chromosomal translocations (Nowell et al., 1960 (Nowell et al., , 1990 Rabbitts, 1994; Solomon et al., 1991; Korsmeyer, 1992; Look, 1997) . In many cases, regulatory elements of either Ig genes or T cell receptor genes become juxtaposed to proto-oncogenes, thereby causing their uncontrolled expression. Burkitt's lymphoma is one of the best studied examples among these neoplasms. For the variant t(2;8) translocation, which fuses the c-myc proto-oncogene to the Ig k locus, the elements responsible for c-myc deregulation have been identi®ed as the k intron enhancer, the k 3' enhancer and the MAR element HoÈ rtnagel et al., 1995; Geltinger et al., 1996) . In the case of the t(8;22) variant translocation, which juxtaposes the c-myc gene and the Ig l locus, these elements have remained unidenti®ed. A 12 kb fragment from the region 3' to Cl7 encompassing the human l enhancer (Blomberg et al., 1991; Glozak et al., 1996) , proved fully able to deregulate c-myc expression in a manner identical to that in BL. Truncated versions or the l enhancer alone were not sucient to induce these eects. On the one hand, these ®ndings implied additional elements that beside the l enhancer must be located on this fragment, while on the other hand, spacing eects could account for the results presented here. The latter is unlikely, since Mautner et al. (1995) have shown that the insertion of a 30 kB fragment of the 3' region of cmyc in the plasmid does not aect transcriptional activation by Ig k elements after stable transfection into BL Raji cells. Furthermore, in transient transfection assays in various BL cell lines, we could not detect any dierence when the 12 kb fragment was inserted in the opposite direction, juxtaposing the l enhancer close to the activated promoter (data not shown). In chromatin analyses of the endogenous human l locus, Asenbauer and Klobeck (1996) identi®ed three DNaseI HSSs within this region; one of these corresponded to the l enhancer, while the other two were associated with elements of unknown function. The latter two HSSs were formed in addition to the l enhancer in BL cell lines and all mature B-cell-lines, regardless of which immunoglobulin light chain was produced, but did not appear in proB-and preB-celllines. This indicates a stage speci®c function. Furthermore, the formation of the HSSs was correlated with their enhancer activity. This together with our ®ndings Figure 4 Chromatin analysis of the 12 kb l-fragment. Nuclei of Raji cells stably transfected with construct pBC83 were isolated and partially digested with DNaseI as described in Materials and methods. Nuclease treated DNA was cut with either BglII or HindIII and separated in a 0.7% agarose gel. After Southern blotting, the DNA was hybridized with a 32 P-labeled fragment spanning c-myc exon 3 or the hygromycin gene. Fragments detected are designated by numbers (HSSI ± III) according to Asenbauer and Klobeck (1996) . The hypersensitive sites within EBV oriP correspond to sites described by Mautner et al. (1995 Mautner et al. ( , 1996 . HSSIII corresponds to the human l enhancer (Blomberg et al., 1991; Glozak et al. 1996) . The triangles above the autoradiogram indicate increasing concentrations of DNaseI. HindIII digested DNA of the phage l served as a size marker c-myc deregulation in Burkitt's lymphoma A Gerbitz et al supports the hypothesis that these elements are involved with and required for c-myc deregulation in BL, since BL is a tumor of immature B-cells (Asenbauer et al., submitted).
Since episomally replicating minichromosomes adopt a chromatin structure indistinguishable from chromosomes (Adams et al., 1993; Felsenfeld, 1992; HoÈ rtnagel et al., 1995; Mautner et al., 1996 , we mapped DNaseI hypersensitive sites within the transfected l fragment. In addition to the previously described HSSs, we detected a new hypersensitive site (HSS 0) at the very 5' end of the 12 kb fragment. Despite its low sensitivity to DNaseI cleavage and the lack of any enhancer function in transient expression assays, the importance of this site for c-myc activation after stable transfection was evident in both S1 nuclease and Northern blot experiments. Such characteristics are reminiscent of MAR elements. These elements control gene expression by supposedly altering the chromosomal structure. Assessment of their regulatory function is therefore dependent upon the nucleosomal organization of the DNA (Klehr et al., 1991) and remains undetected in transient assays where naked DNA is examined. Madisen and Groudine (1994) showed that elements other than the Ca-enhancer were also necessary for c-myc deregulation in a murine mouse plasmacytoma. Interestingly, one of these elements displayed hypersensitivity to DNaseI but no enhancer activity in transient transfection assays. Similar results have been reported for the MAR element in the Ig k locus (Blasquez et al., 1989; HoÈ rtnagel et al., 1995) . This element forms a DNaseI hypersensitive site in B-cells and is indispensible for cmyc deregulation in BL, but again, does not show enhancer activity in transient assays (HoÈ rtnagel et al., 1995) . Whether or not the element residing within HSS 0 serves a similar function remains to be determined, but its properties are consistent with ®ndings reported by other groups (Aronow et al., 1995; Bergman et al., 1984; Forrester et al., 1994; Hug et al., 1992; Queen et al., 1984; Stief et al., 1989) .
The precise mechanism of interaction between enhancers and promoters is not well understood. Thè looping model' proposes that factors bound to a promoter and its enhancer interact directly, thereby bridging regulatory elements over what are often considerable distances. This model presupposes at least basal activity of a promoter in order for it to be able to interact with an enhancer. Deletion analysis of the c-myc promoter identi®ed the immediate upstream region (7101 relative to P1) as sucient for activation by the l locus. DesJardin et al. (1993) and Geltinger et al. (1996) showed that basal transcription and activation of c-myc by the Ig k elements is dependent on the presence of three elements within this promoter fragment, two Sp1 binding sites and the TATA box. The results presented here are consistent with these ®ndings. Furthermore, mutation of one of these sites abolished activation through the l locus in transient transfection assays (data not shown). Our experiments also demonstrate that basal transcription and activation of the c-myc promoter are mediated by elements in the c-myc promoter region other than those that induce the promoter shift. This raises the intriguing possibility that dierent elements in the Ig loci interact with dierent elements in the c-myc promoter and could explain the observed synergistic eect of the l elements on c-myc activation. Studies using various combinations of c-myc promoter fragments and Ig l elements would be required to test this hypothesis. Besides the strong transcriptional activation and induction of the promoter shift, the notion that all elements necessary for the BL-speci®c c-myc deregulation are present on the 12 kb l-fragment is further supported by another line of evidence. As has been demonstrated previously (Polack et al., 1987 , treatment of BL cells with sodium butyrate speci®cally decreases c-myc transcription from the translocated allele. In BL cells with variant translocations, repression of the P1 promoter accounts for most of this transcriptional downregulation. The constructs pBC83 and pAG132, which had shown maximal cmyc activation, responded to sodium butyrate treatment with a drastic downregulation of P1 transcription. The only well established eect of sodium butyrate is inhibition of histone deacetylase leading to an accumulation of hyperacetylated histones and changes in the accessibility of DNA to transcription factors (Lee et al., 1993) . How sodium butyrate speci®cally peturbates the interaction of the l enhancer with P1 remains to be determined.
From this study, together with those on the heavy chain (Madisen et al., 1994) and the k locus (HoÈ rtnagel et al., 1995; Polack et al., 1991 Polack et al., , 1993 , a common picture as to what elements in the immunoglobulin loci deregulate c-myc in BL cells. In each case at least three regulatory elements are required for c-myc deregulation: two transcriptional enhancers and an element which organizes the chromatin structure. This complex regulatory mechanism probably re¯ects the requirement for lineage and dierentiation speci®c regulation and enhanced Ig expression in B cells, which is presumably best achieved by a synergistic interaction between dierent control elements. Not only single elements but the interplay of more than one element ensures the dierentiation-speci®c gene regulation and has led to the concept of a`locus control region' (LCR) which is necessary for organizing structure and transcriptional activation of the locus. These groups of elements are de®ned as activators of transcription which act independent of position, but dependent upon the number of copies per cell (Breznick et al., 1997; Grosveld et al., 1987; Madisen et al., 1994) . The strong transcriptional activation caused by the interplay of these elements also seems to be required in order to override the complex regulation of the c-myc gene. In case of the t(8;22) translocation it remains to be elucidated, how these elements and various combinations thereof contribute to the BL speci®c c-myc deregulation. Furthermore, these constructs should be tested in conjunction with dierent c-myc promoter fragments. This will contribute not only to our understanding of the mechanisms which govern c-myc deregulation in Burkitt's lymphoma, but also to the function of regulatory elements within the l light chain locus itself.
Material and methods

DNA constructs
The constructs pRF115-3 and pRF245-10 are described in Polack et al. (1993) . The 12 kb BglII-BglII l-fragment encompassing the region 3' of Cl7 is derived from cosmid ST107 (Asenbauer et al., 1996) and was inserted downstream of c-myc in pRF115-3 to give rise to plasmid pBC83. pBC164, pBC123 and pBC68 are derivatives of pBC83, generated by using the restriction sites indicated in Figure 1b . The plasmids pAG132 and pAG133 were generated by using the restriction sites KpnI and SmaI Figure 6 The eect of c-myc promoter upstream sequences and sodium butyrate on c-myc promoter usage in Raji cells stably transfected with the constructs pRF115-3, pBC83, pAG132 and pAG133. (a) Histograms (Fujix BAS 1000 phosphoimager) of the signals obtained in the S1 nuclease experiment shown in (b). Dark bars represent transcripts derived from P1, light bars those from P2. Signals marked as P1t and P2t represent the c-myc RNA from the translocated endogenous allele. (b) Total cellular RNA was prepared from sodium butyrate treated as well as untreated cells and c-myc promoter usage examined by S1 nuclease analysis. Butyrate speci®cally downregulates P1 activity but does not aect P2 transcription. These experiments also identify a minimal c-myc promoter fragment as sucient for transcriptional activation by the 12 kb fragment (pAG133), whereas further upstream sequences are required for induction of the promoter shift (pAG132) c-myc deregulation in Burkitt's lymphoma A Gerbitz et al within the c-myc promoter. The c-myc fragments have then been inserted into the polylinker site of the vector pHEBO.
For generating c-myc luciferase constructs the KpnI-XhoI P1 promoter fragment of the human c-myc gene (71058 bp to +66 bp relative to P1) was cloned upstream of the luciferase open reading frame in pBlueluc, giving rise to plasmid pRF211-1. pBlueluc was generated through insertion of the luciferase gene as HindIII-BamHI fragment from SV232AL-Ad5' (kindly provided by de Wet et al., 1987) into pBluescriptIIKS+ (Stratagene). Fragments of the human l locus were cloned into pRF211-1 downstream of the luciferase gene as BamHI-BamHI (pBC154), HindIII-BamHI (pAG110), XhoI-XbaI (pAG112) and ApaI-SacI (pAG113) fragments.
Cell lines, tissue culture and transfection assays
Raji cells and BL60 cells were grown to 3 ± 6610 5 cells per ml in RPMI 1640 medium, supplemented with 10% fetal calf serum, penicillin, streptomycin and L-glutamine. Stable and transient transfections were performed by electroporation as described by Polack et al. (1991 Polack et al. ( , 1993 . Cells were grown for 48 h prior to selection with hygromycin B (Calbiochem). Using Southern blot method, integrity and number of copies of plasmids per cell was estimated by comparison to the number of EBV copies, known to be approximately 100 per Raji cell (data not shown). All stably transfected cell lines contained approximately 20 ± 30 copies of the plasmid.
For transient transfection reporter gene assays protein extracts were prepared from cells grown for 48 h after transfection. Measurement of the luciferase activity in an aliquot of the extracts was determined as described by de Wet et al. with slight modi®cations (de Wet et al., 1987; ZimberStrobl et al., 1993) . Sodium butyrate treatment was carried out by adding sodium-butyrate at a ®nal concentration of 3 mM to the cell culture 4 h prior to harvesting the cells.
Mapping of DNaseI hypersensitive sites
Approximately 5610 8 cells were washed twice in ice-cold phosphate buered saline (PBS). The cells were centrifuged at 500 g and the pellet was resuspended in 50 ml of ice-cold lysis buer (40 mM potassium chloride, 10 mM Tris-HCl pH 7.5, 0.5% NP-40), kept on ice for 10 min and centrifuged at 500 g at 48C. Nuclei were resuspended and lysis buer treatment was repeated. Subsequently, the nuclei were resuspended in 3 ml lysis buer and aliquots of 0.5 ml were distributed in separate tubes to which 50 ml of 50 mM calcium chloride was added. Nuclei were incubated at 158C with increasing amounts of DNaseI (Boehringer-Mannheim) up to 300 U for 15 min. The reaction was stopped by adding 2 ml of STE solution (100 mM Tris-HCl pH 7.5, 50 mM EDTA, 0.5% SDS). DNA was isolated with standard procedures using phenolchloroform-isoamylalcohol extractions and ethanol precipitations and digested to completion over night using either HindIII or BglII restriction enzymes. After separation in a 0.5 ± 0.8% agarose gel, DNA was transferred to a nylon membrane (Hybond N+, Amersham) and hybridized with a randomly primed probe (see Figure 4) in Church buer (0.5 M sodium phosphate, pH 7.2; 7% SDS; 1 mM EDTA) over night. Expression levels were quanti®ed by a Fuji phosphoimager Fujix BAS 1000 (Fuji).
RNA analysis
Total cellular RNA samples were prepared by extraction with guanidinium thiocyanate followed by centrifugation on a caesium chloride gradient (Sambrook et al., 1989) . RNA quantitation, Northern blotting and S1 Nuclease analysis were carried out as described in Eick and Bornkamm (1989) . Expression levels were quanti®ed by using a Fujix BAS 1000 phosphoimager (Fuji).
